PATRICIA SULLIVAN: Open Payments
NPI 1376870097 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 18 payments from 6 companies in 2025. Trend: 2023 $82 · 2024 $140 · 2025 $385
Food & beverage: $296Education: $89
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $141 |
| SANOFI-AVENTIS U.S. LLC | 1 | $89 |
| GENZYME CORPORATION | 3 | $65 |
| Hikma Pharmaceuticals USA | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
Products named: DUPIXENT, NUCALA, Ryaltris, Rhapsido.
Industry payments across AZ — which companies pay providers there.
